Supplementary Tables 1 - 3 from High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma

PDF file - 33K, Sequences for pLKO.1 FAK-targeting and CAS-targeting shRNAs (S1); Median fluorescent intensity for six Ewing sarcoma cell lines and 293FT cells measuring the phosphorylation level of 62 tyrosine kinases (S2); PF-562271 downregulates mTOR, AKT, and S6 phosphorylation (S3).